Stockscreener 앱 받기
95.41
1.24%
1.175
전일 마감가:
$94.23
열려 있는:
$94.65
하루 거래량:
1.02M
Relative Volume:
0.17
시가총액:
$295.89B
수익:
$58.07B
순이익/손실:
$9.40B
주가수익비율:
31.68
EPS:
3.0113
순현금흐름:
$9.87B
1주 성능:
+6.07%
1개월 성능:
+2.69%
6개월 성능:
+31.29%
1년 성능:
+36.12%
1일 변동 폭
$94.65
$95.52
1주일 범위
$89.04
$95.52
52주 변동 폭
$61.24
$96.51
아스트라제네카 ADR Stock (AZN) Company Profile
명칭
Astrazeneca PLC
전화
44 20 3749 5000
주소
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge
AZN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AZN
Astrazeneca PLC
|
95.43 | 292.17B | 58.07B | 9.40B | 9.87B | 3.0113 |
아스트라제네카 ADR Stock (AZN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-27 | 재개 | Jefferies | Buy |
| 2025-10-16 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2025-04-15 | 개시 | Exane BNP Paribas | Outperform |
| 2025-02-13 | 업그레이드 | UBS | Neutral → Buy |
| 2025-02-12 | 개시 | Morgan Stanley | Overweight |
| 2024-11-20 | 업그레이드 | UBS | Sell → Neutral |
| 2024-11-06 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-09-13 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-04-16 | 업그레이드 | Deutsche Bank | Sell → Hold |
| 2024-02-08 | 다운그레이드 | Deutsche Bank | Hold → Sell |
| 2024-01-23 | 개시 | Morgan Stanley | Overweight |
| 2024-01-16 | 재개 | UBS | Sell |
| 2024-01-03 | 다운그레이드 | Jefferies | Buy → Hold |
| 2023-12-18 | 개시 | HSBC Securities | Buy |
| 2023-09-25 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-07-14 | 개시 | HSBC Securities | Buy |
| 2023-07-12 | 업그레이드 | UBS | Neutral → Buy |
| 2023-07-05 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2023-04-11 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-01-05 | 개시 | BMO Capital Markets | Outperform |
| 2022-09-15 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2022-09-07 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-29 | 업그레이드 | Argus | Hold → Buy |
| 2022-06-14 | 다운그레이드 | UBS | Buy → Neutral |
| 2022-02-11 | 업그레이드 | DZ Bank | Sell → Hold |
| 2021-12-07 | 다운그레이드 | Jefferies | Buy → Hold |
| 2021-08-12 | 재개 | JP Morgan | Overweight |
| 2021-04-12 | 다운그레이드 | Argus | Buy → Hold |
| 2021-03-16 | 업그레이드 | Jefferies | Hold → Buy |
| 2021-02-25 | 업그레이드 | UBS | Neutral → Buy |
| 2021-01-15 | 개시 | Deutsche Bank | Buy |
| 2020-12-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-11-30 | 업그레이드 | UBS | Sell → Neutral |
| 2020-11-11 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2020-09-29 | 개시 | Berenberg | Buy |
| 2019-11-22 | 개시 | SVB Leerink | Outperform |
| 2019-10-25 | 업그레이드 | Liberum | Hold → Buy |
| 2019-04-02 | 다운그레이드 | UBS | Neutral → Sell |
| 2019-02-05 | 개시 | Exane BNP Paribas | Outperform |
| 2019-01-25 | 업그레이드 | Shore Capital | Hold → Buy |
| 2018-12-11 | 재개 | Jefferies | Hold |
| 2018-10-09 | 개시 | Guggenheim | Buy |
| 2018-08-16 | 다운그레이드 | Jefferies | Buy → Hold |
| 2018-03-19 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-02-06 | 재확인 | Leerink Partners | Mkt Perform |
| 2018-02-05 | 재확인 | Bernstein | Outperform |
| 2018-01-18 | 재확인 | Leerink Partners | Mkt Perform |
| 2017-12-29 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-10-16 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2017-09-25 | 업그레이드 | Exane BNP Paribas | Neutral → Outperform |
| 2017-09-22 | 업그레이드 | Bernstein | Mkt Perform → Outperform |
모두보기
아스트라제네카 ADR 주식(AZN)의 최신 뉴스
AstraZeneca the 'top pick' among European pharmasbroker - Proactive Investors
Vanguard Personalized Indexing Management LLC Raises Holdings in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca and GSK to accompany Keir Starmer to China to strengthen economic cooperation - marketscreener.com
Why Astrazeneca (AZN) Outpaced the Stock Market Today - Yahoo Finance Singapore
Decliners Report: Why is AstraZeneca PLC Depositary Receipt stock going upJuly 2025 Gainers & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Drugmakers AstraZeneca, GSK to join Starmer delegation to China, sources say - Reuters
Corticosteroids Market Report 2026 - GlobeNewswire Inc.
Y Intercept Hong Kong Ltd Has $5.11 Million Stock Position in AstraZeneca PLC $AZN - MarketBeat
Oxbow Advisors LLC Boosts Stock Position in AstraZeneca PLC $AZN - MarketBeat
Jennison Associates LLC Sells 8,481,701 Shares of AstraZeneca PLC $AZN - MarketBeat
Risk Hedge: Is AstraZeneca PLC Depositary Receipt vulnerable to short sellersQuarterly Profit Summary & Accurate Entry/Exit Alerts - baoquankhu1.vn
AstraZeneca (LON:AZN) Shares Cross Above Two Hundred Day Moving AverageWhat's Next? - MarketBeat
US court: AstraZeneca, Johnson & Johnson, Pfizer, Roche and other pharmaceutical companies must face allegations of aiding terrorist organizations in Iraq - Bitget
AstraZeneca's Tagrisso® and Calquence® Among First Oncology Treatments Granted Accelerated Access Through Ontario's FAST Program – Company AnnouncementFT.com - Financial Times
Looking for Growth Opportunities Outside the U.S. Market? This International ETF Soared Past the S&P 500 Last Year - The Motley Fool
AstraZeneca plc: How a Reinvented Pharma Powerhouse Turned Its Pipeline Into a Platform - AD HOC NEWS
Daiichi Sankyo and AstraZeneca’s Enhertu gains NMPA approval for HER2 GEJ - Pharmaceutical Technology
AstraZeneca plc Stock Is Quietly Going Off — Is This Your Next Power Move? - AD HOC NEWS
Migdal Insurance & Financial Holdings Ltd. Acquires Shares of 194,000 AstraZeneca PLC $AZN - MarketBeat
Prediction: Analysts think the AstraZeneca share price will do this in 2026 - MSN
Eyes on Asia: AirNexis, AstraZeneca, Syngene International - BioXconomy
AstraZeneca - Britannica
Astrazeneca expands China cell therapy footprint with Abelzeta CAR T - BioWorld MedTech
AstraZeneca stock price slides as AZN sets Nasdaq exit, NYSE move dates - TechStock²
AstraZeneca to delist from Nasdaq, join NYSE in February - Reuters
Why Is AstraZeneca Stock Trading Lower Today?AstraZeneca (NASDAQ:AZN) - Benzinga
AstraZeneca to move NYSE listing, withdraw from Nasdaq at end of January By Investing.com - Investing.com South Africa
AstraZeneca (AZN) Shifts Listing from Nasdaq to NYSE - GuruFocus
AstraZeneca to move NYSE listing, withdraw from Nasdaq at end of January - Investing.com
Dynasty Wealth Management LLC Invests $3.27 Million in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca to complete direct listing in NY on February 2 - marketscreener.com
AstraZeneca PLC (AZN) Gains After Successful Saphnelo Trial - Finviz
AstraZeneca PLC (NASDAQ:AZN) Emerges as a Quality Investment Candidate - Chartmill
AstraZeneca (AZN) to Consolidate Stock Listings on NYSE - GuruFocus
AstraZeneca To Move Nasdaq Listing To NYSE - DirectorsTalk Interviews
AstraZeneca Plans NYSE Listing for Shares, US Debt - Mirage News
AstraZeneca to complete direct listing of ordinary shares and all US debt securities on the New York Stock Exchange - AstraZeneca
AstraZeneca (AZN): EMA Considers Enhertu for Breast Cancer Treat - GuruFocus
AstraZeneca share price slips in London as tariff threat rattles markets; EMA review and earnings in focus - TechStock²
AstraZeneca's Subcutaneous Saphnelo Shows Significant Disease Reduction in Landmark Lupus Trial - Finviz
AstraZeneca’s Subcutaneous Saphnelo Shows Significant Disease Reduction in Landmark Lupus Trial - Yahoo Finance
AstraZeneca to acquire China rights for AbelZeta’s CAR-T therapy - Yahoo Finance
Prediction: analysts think the AstraZeneca share price will do this in 2026 - Yahoo Finance UK
AbelZeta and AstraZeneca Reach $630 Million Acquisition Agreement - Intellectia AI
AstraZeneca PLC (NASDAQ:AZN) Short Interest Update - MarketBeat
AstraZeneca PLC $AZN Shares Sold by QRG Capital Management Inc. - MarketBeat
AstraZeneca PLC $AZN Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
AstraZeneca PLC agreed to acquire remaining 50% stake in China rights to GPC3 armored CAR-T therapy from Abelzeta Inc. for $630 million. - marketscreener.com
Trend Review: Does AstraZeneca PLC Depositary Receipt have a sustainable dividendEarnings Miss & Weekly High Momentum Picks - baoquankhu1.vn
AstraZeneca share price steadies after Thursday drop as traders eye Nasdaq-100 reshuffle - TechStock²
Klein Pavlis & Peasley Financial Inc. Acquires New Position in AstraZeneca PLC $AZN - MarketBeat
아스트라제네카 ADR (AZN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):